Neurobiol Dis., 2015 · DOI: 10.1016/j.nbd.2014.12.003 · Published: February 1, 2015
This research explores the role of neutrophil elastase (NE), an enzyme released by immune cells, in brain injury in young mice. The study found that NE contributes to early brain damage after trauma. The researchers used genetic and drug-based methods to reduce NE activity. Reducing NE improved long-term behavioral outcomes in the injured mice. These findings suggest that targeting NE could be a potential therapeutic strategy for treating traumatic brain injury in children.
Neutrophil elastase (NE) is a potential therapeutic target for pediatric traumatic brain injury (TBI).
Acute intervention targeting NE may be beneficial in reducing initial damage following TBI.
Prolonged or repeated treatment strategies may be needed to address the extended inflammatory response observed in the immature brain following injury.